Human Amniocytes Regulate Serotonin Levels by Active Uptake and Express Genes Suggestive of a Wider Role in Facilitating Neurotransmitter Regulation in the Fetal Environment
- 1 February 2011
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 20 (2) , 341-349
Abstract
Fetal serotonin levels, which mediate multiple developmental processes, are highly regulated. However, an incomplete picture exists on the component parts of such regulation during fetal growth. Serotonin and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) are found in the amniotic fluid, also containing significant numbers of amniocytes, previously thought to be the result of cell shedding as a byproduct of growth. The aim of the present study was to examine human amniocytes as a potentially active and dynamic component of serotonin regulation in the fetal environment. Using amniocytes derived from multiple donors of amniocentesis, we found all components necessary for serotonin metabolism. We identified a strong expression of the serotonin transporter and confirmed the high-affinity serotonin transporter–mediated uptake of serotonin (5-HT), along with uptake via the norepinephrine transporter, and an evidence of 5-HT breakdown due to the expression of the degradative enzymes monoamine oxidase A and B. Additionally, wider expression analysis for biogenic amine and cholinergic metabolism suggests a capability for cholinergic synthesis and release and for catecholamine storage. Our results shed new light on amniocytes, consistent with a role in the homeostasis of neurotransmitters during fetal development. Moreover, these results may provide clinical significance for amniocytes as new targets for uptake inhibitors such as tricyclic antidepressants, selective serotonin reuptake inhibitors, and drugs of abuse such as cocaine, with implications on their regulation during pregnancy. This work shows for the first time an inherent in vivo function of amniocytes and more broadly implicates them as a new and active component of the fetal–maternal regulatory system.Keywords
This publication has 43 references indexed in Scilit:
- Embryonic depletion of serotonin affects cortical developmentEuropean Journal of Neuroscience, 2007
- Effect of MAO A deficiency on different kinds of aggression and social investigation in miceAggressive Behavior, 2006
- Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin ConcentrationsArchives of General Psychiatry, 2003
- Altered zincergic innervation of the developing primary somatosensory cortex in monoamine oxidase-A knockout miceDevelopmental Brain Research, 2003
- Activation of 5-HT Receptors That Stimulate the Adenylyl Cyclase Pathway Positively Regulates IGF-I in Cultured Craniofacial Mesenchymal CellsDevelopmental Neuroscience, 2001
- Placenta Detachment: Unexpected High Concentrations of 5-Hydroxytryptamine (Serotonin) in Fetal Blood and its Mitogenic Effect on Placental Cells in BovinePlacenta, 2001
- Regional Differences in the Ontogeny of the Serotonergic Projection to the Cerebral CortexExperimental Neurology, 1996
- Expression of a Serotonin-Gated Ion Channel in Embryonic Neural and Nonneural TissuesMolecular and Cellular Neuroscience, 1995
- Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimesterDevelopmental Brain Research, 1993
- Difference in the concentration of tryptophan metabolites between maternal and umbilical foetal bloodJournal of Chromatography B: Biomedical Sciences and Applications, 1992